Document is current
Any future updates will be listed below
-
Authors
Peng, Wenjuan
Xie, Yunyi
Xia, Juan
Li, Bingxiao
Zhang, Fengxu
Wen, Fuyuan
Liu, Kuo
Cao, Han
Qi, Han
Zhang, Ling https://orcid.org/0000-0003-2468-864X
-
Funding
Funding for this research was provided by:
Natural Science Foundation of China (81973121, 81373076)
National Key Research and Development Program of China (2016YFC0900603)
- License Information
-
More Information
Article History
Received: 31 August 2021
Accepted: 16 November 2021
First Online: 2 December 2021
Declarations
:
: This study complied with the ethical standards of the institutional research committee, the Helsinki Declaration of 1964 and its subsequent modifications, or comparable ethical standards. The study protocol was analyzed and approved by the Ethics Committee of the Capital Medical University. All subjects in the study signed an informed consent.
: The authors declare no competing interests.
: The existing diagnostic methods for SS are laborious and costly. In the current study, we identified lncRNAs as potential circulating biomarkers for SS and evaluated the efficiency of lncRNAs for diagnosing SS. This study provided a theoretical basis for early screening of SS, which may help to implement salt-limiting interventions at an early stage, thereby reducing the burden of cardiovascular diseases.
